Paas medical information

[^7[^1HD^7] !LLÆ]

So, you want to be watching Dr John Campbell videos on Youtube the ones with Professor Angus Dalgleish are very specific because he has been keeping stage 4 cancer patients alive for 18 years. You need to be ordering Ivermectin. If you have no tumours you need the Tuberculosis vaccine not the mRNA version the old normal version, this puts vitamin D levels the highest they can be in a human. Id take some serious doses over a short period of psilocybin to reset all the shit in your brain so it can effectively tell your body where it needs to be fighting the cancer. Take an aspirin every day, it forms shield around cells that makes them harder to be infiltrated by cancer cells. Some people have been cured through the mushroom turkey tail but everyones mutations are unique so what may work for one person may not for another. Start getting tattoos to trigger more white blood cell production, people who get tattoos regularly have 10-20% more white blood cells than a normal person. None of these things will harm you so you have nothing to lose. Although doctors and so on mean well, they are all manipulated by the pharma companies and if you watch a lot of Campbell videos the amount of times they publish scientific data the pharma companies will just ignore it and carry on with treatments that are shown to be ineffective or make the patient worse which is only what doctors are legally allowed to work with. In his videos he says 'I cant tell you to take these drugs' because he cant legally, but he can tell you the outcomes from people taking these drugs...

[^6P^7aasH^6aa^7s]

Read about it x,

Thx for effort and explaining, but not sure if im going that way.

[^6z^7j^6☻^7!]

Campbell also has a few videos about ivermectine and fenbendazol. If you need some ivermectin, contact me

[^7[^1HD^7] !LLÆ]

Rich,

Many thanks for the contact and I apologize for the delay in answering. I've been out of town for a few weeks and just catching up now.

Someday we'll do something like you're suggesting, but with the state of health care in the US right now, I don't see it happening. Insurance companies are destroying health care, so I cannot even imagine who would pay for these kinds of therapies unless one is rich.

But you are assuredly on the right path for what could be done.

Best,

Garry P. Nolan

===============================================================

Garry P. Nolan, Ph.D.

Rachford and Carlota A. Harris Professor

[^7[^1HD^7] !LLÆ]

So, what you need to do is sequence your genome to the maximum it can be done then the data of your genome needs to be analysed by the highest levels possible for AI to predict the mutated cancerous genes and then use gene editing technology CRISPR to rewrite the genetic code. How do I send an email about how to stop cancer at 03/11/2025 at 01:55 in the morning to a Stanford professor and he replies and says you know it all...

[^7[^1HD^7] !LLÆ]

New cancer prevention and treatment
Dr. John Campbell
3.32M subscribers
Jul 3, 2026
By Prof Angus Dalgleish MD FRCP FRACP FRCPath FMedSci
My name is Professor Angus Dalgleish. I am an oncologist and immunologist with decades of experience in cancer immunotherapy and HIV research, including early clinical use of cancer immunotherapy in the United Kingdom long before checkpoint inhibitors were approved. I am Professor Emeritus and Foundation Chair of Oncology at the University of London, and Principal of the Institute of Cancer Vaccines and Immunotherapy.
Beginning in late 2021, I observed a series of unexpected cancer relapses and unusually aggressive disease presentations among patients whose conditions had remained stable for years.
A consistent pattern quickly became apparent: these relapses followed repeated COVID booster administration.
These were patients in long-term remission who suddenly relapsed after being advised to receive additional doses of the vaccine.
Despite the seriousness of these observations, there was little willingness to openly investigate these potential safety signals.
From my background in HIV research and immunology, including early work involving the CD4 receptor, I was particularly sensitive to signals involving T-cell function and immune dysregulation. This led me to become concerned that repeated boosting strategies might contribute to impaired immune surveillance in vulnerable individuals, a concern later supported by evidence of exhausted T-cell responses following repeated vaccination.
Over time, however, it became increasingly clear that the pattern extended far beyond relapse in vulnerable cancer patients alone.
I began observing something far more alarming: unusually aggressive cancers, advanced-stage disease in younger individuals, and clinical presentations that differed sharply from what we would normally expect in routine oncology practice. Something broader — and far more concerning — appeared to be emerging.
In my own clinical practice, I observed a marked increase in unexpected cancers among boosted patients, including breast, prostate, pancreatic, lymphoma, gall bladder, glioma, and bladder cancers.
Some of the most striking observations came from colorectal cancer surgeons, who described a shift from earlier-stage, more routinely detected disease toward patients presenting with metastatic stage IV cancers and unusual thrombotic features.
Increasingly, these patterns extended beyond clinical settings and into personal lives. I watched close friends develop aggressive late-stage cancers and rapidly deteriorate following repeated booster administration.
At that point, the issue no longer felt purely academic or theoretical. It became deeply personal.
I became increasingly concerned by unresolved questions surrounding the biologic behavior of mRNA-based platforms.
Emerging literature proposed several biologically plausible mechanisms linking these vaccines to cancer progression, including immune dysregulation, vascular injury, and effects involving oncogenic and tumor-suppressor pathways.
Additional issues involved residual DNA fragments and SV40 promoter/enhancer sequence elements identified in certain vaccine lots, findings which I believe warranted far greater regulatory scrutiny and independent investigation given their potential oncogenic implications.
Through my previous work with mRNA experts and service on the Scientific Advisory Board of CureVac, I also became increasingly uneasy about questions involving biologic stability, genomic interaction, and the adequacy of long-term safety evaluation surrounding repeated mRNA exposure. For example, unresolved questions remain regarding potential interactions with cellular genetic processes, potentially activating cancer-promoting pathways while disrupting tumor suppression.
The consistency of these clinical observations, combined with emerging mechanistic evidence, should have prompted far greater scientific scrutiny and open investigation than they received.
Instead, many clinicians and researchers became increasingly hesitant to openly question or investigate these potential safety signals at all. As a UK citizen, I found it striking that several members of the Royal Family, who were vaccinated, publicly disclosed unexpected cancer diagnoses during the same period many clinicians were reporting unusually aggressive cancers more broadly. Given what we know already, I have no doubt in my mind that the mRNA vaccine likely played a significant role in the development of these unexpected cancers. I raise this not to imply certainty regarding any individual case, but to illustrate how difficult open scientific discussion surrounding these broader patterns has become, even when the observations are highly visible.